CRP and COVID-19: The evidence of the effect of IMM formulas in critically ill patients with COVID-19 is much more limited, and studies have found few benefits when using this type of formula, as demonstrated by the clinical trial of Pimentel et al.,(22) which reported a decrease in the levels of C-reactive protein in patients receiving an IMM formula, with no significant effect on any other variable.